Exposure to Plastics Chemical BPA May Raise Diabetes Risk
July 5, 2024
Micronutrients and the Brain: The Potential to Transform Mental Health Care
July 5, 2024

United States Poised to Invest Millions in mRNA Bird Flu Vaccine Amid H5N1 Scare

Share this post:


The US government is poised to announce a multimillion-dollar investment in mRNA vaccines for H5N1 bird flu. The move comes as the virus continues to spread in mammals, threatening a new pandemic if it makes the jump to humans.
[Source: telegraph.co.uk]

[Image source: Adobe Stock]


This initiative involves the US government’s Biomedical Advanced Research and Development Authority (BARDA) negotiating a deal with Moderna to fund human trials of an experimental mRNA bird flu vaccine, with a commitment to later potentially stockpile millions of doses. The H5N1 bird flu virus has a 50 percent fatality rate in humans and has caused over 400 deaths over the past 20 years.

The virus’s recent spread into US cattle and its ability to infect a variety of mammals have heightened concerns about its potential to mutate and spread among humans. In addition to Moderna, the US government is also said to be in talks with Pfizer about developing an mRNA vaccine for the virus. Having already profited massively from the COVID-19 pandemic, vaccine makers are increasingly eyeing the H5N1 bird flu virus as their next potential money-spinner.

To read how, responding to a bird flu scare in 2006, Dr. Rath described in the New York Times how vitamins, minerals, plant polyphenols, and other nutrients present effective, safe, and affordable options for fighting the disease, see this open letter on our website.

Share this post: